Our built-in tools help you complete, sign, share, and store your documents in one place.
Make edits, fill in missing information, and update formatting in US Legal Forms—just like you would in MS Word.
Download a copy, print it, send it by email, or mail it via USPS—whatever works best for your next step.
Sign and collect signatures with our SignNow integration. Send to multiple recipients, set reminders, and more. Go Premium to unlock E-Sign.
If this form requires notarization, complete it online through a secure video call—no need to meet a notary in person or wait for an appointment.
We protect your documents and personal data by following strict security and privacy standards.

Make edits, fill in missing information, and update formatting in US Legal Forms—just like you would in MS Word.

Download a copy, print it, send it by email, or mail it via USPS—whatever works best for your next step.

Sign and collect signatures with our SignNow integration. Send to multiple recipients, set reminders, and more. Go Premium to unlock E-Sign.

If this form requires notarization, complete it online through a secure video call—no need to meet a notary in person or wait for an appointment.

We protect your documents and personal data by following strict security and privacy standards.
Novavax's 2023–2024 vaccine is no longer available in the U.S., since all doses have expired. Who can get it: People 12 and older. People 65 years and older, and those who are moderately or severely immunocompromised may receive a second dose six months after their first dose.
Vaccines are offered at the following locations: Peel Public Health vaccine clinics. Pharmacies and primary care providers. Peel Public Health in-home appointments for homebound residents.
Nuvaxovid JN. 1, developed by Novavax, is a vaccine licensed for adults and those aged 12 years and older. The vaccine has been approved by the MHRA under the International Recognition Procedure, after confirming it meets the UK regulator's standards of safety, quality, and efficacy.
Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) is authorized for use in individuals 12 years of age and older as follows: Individuals who have never been vaccinated with any COVID-19 vaccine: two doses of Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) are administered three weeks apart.
Everyone ages 6 months and older should get a 2024–2025 COVID-19 vaccine. The COVID-19 vaccine helps protect you from severe illness, hospitalization, and death.